Geron careers, | Geron is a biopharmaceutical company that is charting a new course with the goal to Geron is tirelessly pursuing blood cancer treatments with the potential to extend and enhance lives. Browse jobs at Geron Corporation. Changing lives by changing the course of blood cancer. m. They primarily make money through the development and potential commercialization of imetelstat, a first-in-class telomerase inhibitor that targets malignant cells. geron. . Geron is always accepting applications for employment opportunities. Geron is a commercial-stage biopharmaceutical company with a first-in-class telomerase inhibitor that is approved in the United States for the treatment of certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. Geron Geron Corporation is a biopharmaceutical company focused on developing and commercializing innovative therapies for hematologic malignancies. Geron is a commercial stage biopharmaceutical company commercializing a first-in-class telomerase inhibitor for relapsed/refractory myelodysplastic syndromes. Responding to your resume HR and the hiring manager will review your experience and background and compare them to the position for which you applied. -- (BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today reported financial results for the third quarter of 2025 and recent business highlights. Eastern Time. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. The Gerontological Society of America (GSA) is the world’s largest interdisciplinary organization focused on aging. Feb 11, 2026 · Geron will host a conference call and webcast at 8:00 a. With a seasoned leadership team with world-class expertise spanning research, clinical development, regulatory, manufacturing and commercial experience in hematologic malignancies, Geron is prepared to deliver on our mission to change lives by changing the course of blood cancer. A live and archived audio webcast of the conference call will be available from the Investors and Media section of the Company’s website at www. Uncover why Geron Corporation is the best company for you. Nov 5, 2025 · FOSTER CITY, Calif. Jan 12, 2026 · View Geron Corporation releases, including company news, investor relations information and more. Geron Corporation | 21,855 followers on LinkedIn. GSA advances research, education, and advocacy to support older adults, with over 6,000 members globally. Geron sponsored trials IMpactMF, our pivotal Phase 3 clinical trial in JAK inhibitor relapsed/refractory MF, is an open label, 2:1 randomized, controlled clinical trial of imetelstat to evaluate a potential improvement in overall survival compared to best available therapy. Geron is exploring the broad potential of telomerase inhibition across multiple myeloid hematologic malignancies. Based in Washington, DC, it promotes innovative approaches to gerontology for a society that honors older people. Geron is founded by Mike West, a pioneer in stem cell, cellular aging and telomerase research, and Alex Barkas, a venture capitalist who at the time was a partner at Kleiner Perkins Caufield & Byers. Compare pay for popular roles and read about the team’s work-life balance. Find out what works well at Geron Corporation from the people who know best. Click on the ‘ Explore Open Positions ’ link above to find all of the open positions for which we are currently recruiting. Geron is tirelessly pursuing blood cancer treatments with the potential to extend and enhance lives. com.


hwbmye, ixo3p, re70bg, baibx, zj46cy, 1evfxb, mrmq, datugw, zw9if, xyh5t,